je.st
news
Supreme court ruling in drug case has broad implications for tech sector
2015-01-21 17:15:09| Biotech - Topix.net
Erik Belt is an intellectual property lawyer at McCarter & English in Boston and president-elect of the Boston Patent Law Association. A Supreme Court ruling yesterday shooting down a local biotech firm's hopes of launching a generic version of a multiple sclerosis drug before September has ramifications far beyond the pharmaceutical industry, say patent lawyers.
Tags: case
tech
court
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|